входит в структуру портала
EATG, Uncategorized, News

The HCV care continuum does not end with cure: A call to arms for the prevention of reinfection

January 19, 2017

After the approval of safe and highly effective oral direct acting agents (DAA) for the treatment of hepatitis C virus (HCV) in 2014, commentaries and discussions about the elimination of hepatitis C on a population level have rapidly proliferated in scientific literature and popular press. Indeed, the World Health Organization (WHO) has announced proposed global targets of an 80% reduction in new cases of HCV infection from the 2010 level and several countries, including Australia, Egypt, Georgia and Iceland have embarked on ambitious plans to control HCV infection in their populations.

To read the full article, published in Journal of Hepatology, click here.

Original Article

Remember me
Lost your Password?
Password Reset